Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/22/1998WO1998021223A1 Nucleosides
05/22/1998WO1998021222A2 1-galactose derivatives
05/22/1998WO1998021221A2 1-thiogalactose derivatives
05/22/1998WO1998021220A2 Saccharide derivatives
05/22/1998WO1998021218A1 Solid support matrices containing a toxin binding oligosaccharide
05/22/1998WO1998021213A2 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
05/22/1998WO1998021212A1 Process for the preparation of salts and esters of clavulanic acid
05/22/1998WO1998021210A1 Tricyclic carbapenem compounds
05/22/1998WO1998021209A1 New imidazopyridines and oxazolopyridines
05/22/1998WO1998021208A1 Benzonaphthyridines as bronchial therapeutics
05/22/1998WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
05/22/1998WO1998021206A1 Piperidine derivatives
05/22/1998WO1998021205A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole
05/22/1998WO1998021204A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
05/22/1998WO1998021203A1 2r,4s,s,r- and 2s,4r,s,r-hydroxyitraconazole
05/22/1998WO1998021202A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/22/1998WO1998021200A1 Certain pyrazole derivatives as corticotropin-releasing factor receptor crf1 specific ligands
05/22/1998WO1998021196A1 Antibiotic tkr2648 and process for producing the same
05/22/1998WO1998021195A1 Indene inhibitors of cox-2
05/22/1998WO1998021194A1 Novel biphenyl dicarboxylic acid derivatives and process for preparing them
05/22/1998WO1998021193A1 Antithrombotic organic nitrates
05/22/1998WO1998021190A1 Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
05/22/1998WO1998021188A1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998021184A1 Process for substituted pyridines
05/22/1998WO1998021183A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
05/22/1998WO1998021182A2 Use of cis-δ4 analogs of prostaglandins as ocular hypotensives
05/22/1998WO1998021181A2 15-fluoro prostaglandins as ocular hypotensives
05/22/1998WO1998021180A1 Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
05/22/1998WO1998021177A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998WO1998021176A1 Novel pseudoceramides, and dermatologic external preparations containing the same
05/22/1998WO1998020907A1 TGFβ1-RESPONSIVE CELLS FROM BONE MARROW
05/22/1998WO1998020893A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020892A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020891A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020884A1 Apoptosis inducers
05/22/1998WO1998020883A1 Use of pvp or povidone for reducing bowel distension
05/22/1998WO1998020882A1 Composition to reduce the level of sugar in the blood
05/22/1998WO1998020881A1 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
05/22/1998WO1998020880A2 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
05/22/1998WO1998020879A1 L-β-DIOXOLANE URIDINE ANALOGS AND METHODS FOR TREATING AND PREVENTING VIRUS INFECTIONS
05/22/1998WO1998020877A1 Thiamine disulfides and medicines containing the same as the active ingredient
05/22/1998WO1998020876A1 Use of cis-hydroxyitraconazole in order to avoid side-effects of itraconazole and hydroxyintraconazole
05/22/1998WO1998020875A1 5-ht1f agonists
05/22/1998WO1998020874A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
05/22/1998WO1998020873A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998WO1998020872A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
05/22/1998WO1998020871A1 Visceral fat lowering agent
05/22/1998WO1998020870A1 Improved treatment of migraine headache
05/22/1998WO1998020869A2 Formulation for electrically assisted delivery of lidocaine and epinephrine
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998WO1998020867A1 Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
05/22/1998WO1998020866A2 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists
05/22/1998WO1998020865A2 Therapeutic uses for nitric oxide inhibitors
05/22/1998WO1998020864A2 Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases
05/22/1998WO1998020857A1 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
05/22/1998WO1998020852A1 Pharmaceutical compositions containing kukui nut oil
05/22/1998WO1998020835A2 Method of treating hyperlipidemia in humans
05/22/1998WO1998020834A2 Method for treatment of dermatological disorders
05/22/1998WO1998020814A1 Nicotine metabolites, nicotine dependence and human body weight
05/22/1998WO1998020736A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES
05/22/1998WO1998015277A3 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents
05/22/1998WO1998010795A3 Tumor homing molecules, conjugates derived therefrom, and methods of using same
05/22/1998CA2539815A1 Solvent-free crystal of benzimidazole derivative and its use
05/22/1998CA2275867A1 Method for treatment of dermatological disorders
05/22/1998CA2272404A1 L-.beta.-dioxolane uridine analogs and methods for treating and preventing virus infections
05/22/1998CA2272066A1 Certain pyrazole derivatives as corticotropin-releasing factor receptor crf1 specific ligands
05/22/1998CA2271849A1 Use of cis-hydroxyitraconazole in order to avoid side-effects of itraconazole and hydroxyintraconazole
05/22/1998CA2271847A1 Process for the preparation of salts and esters of clavulanic acid
05/22/1998CA2271843A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
05/22/1998CA2271832A1 Piperidine derivatives
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271737A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
05/22/1998CA2271734A1 Tgf.beta.1-responsive cells from bone marrow
05/22/1998CA2271732A1 Tricyclic carbapenem compounds
05/22/1998CA2271729A1 Therapeutic uses for nitric oxide inhibitors
05/22/1998CA2271728A1 Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
05/22/1998CA2271724A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998CA2271705A1 Apoptosis inducing agent
05/22/1998CA2271673A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998CA2271325A1 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
05/22/1998CA2271299A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/22/1998CA2271272A1 5-ht1f agonists
05/22/1998CA2271135A1 Nucleosides
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270985A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2270943A1 Use of pvp or povidone for reducing bowel distension
05/22/1998CA2270910A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998CA2270634A1 Methods and compositions for stimulating neurite growth
05/22/1998CA2270629A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2270156A1 Human breast tumor-specific proteins
05/22/1998CA2269855A1 15-fluoro prostaglandins as ocular hypotensives
05/22/1998CA2269853A1 Use of cis-.delta.4 analogs of prostaglandins as ocular hypotensives
05/22/1998CA2269622A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole
05/22/1998CA2269617A1 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
05/22/1998CA2269616A1 2r,4s,s,r- and 2s,4r,s,r-hydroxyitraconazole
05/22/1998CA2269608A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
05/22/1998CA2269035A1 Indene inhibitors of cox-2
05/22/1998CA2268018A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998CA2266890A1 Heterocycle derivatives which inhibit factor xa
1 ... 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 ... 7860